Editorial
Published in:
Volume 4 / Year 2015 / Issue 1
Volume 4 / Year 2015 / Issue 1
Biosimilars: patient and physician acceptability is the fifth hurdle to market competition
Author(s): Professor Alan Lyles, BSPharm, MPH, ScD
Page: 6-7
Page: 6-7
Abstract: Biosimilar products confront novel market authorization and post-marketing use hurdles. Existing evidence is insufficient to fully address physician and payer acceptability thresholds. Submitted: 4 March 2015; Revised: 5 March… Read More »